US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.5946
- -0.0134-2.20%
Close Nov 27 16:00 ET
- 0.5948
- +0.0002+0.03%
Post 16:58 ET
2.91MMarket Cap-9P/E (TTM)
0.6192High0.5618Low88.51KVolume0.5910Open0.6080Pre Close52.29KTurnover1.81%Turnover RatioLossP/E (Static)4.89MShares10.727552wk High2.73P/B2.90MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM9.44%Amplitude0.3610Historical Low0.5900Avg Price1Lot Size
NovaBay Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -77.65%776K | -82.99%751K | -51.33%1.82M | -41.63%3.13M | -41.63%3.13M | -10.24%3.47M | 12.29%4.41M | -33.59%3.75M | -28.54%5.36M | -28.54%5.36M |
| -Cash and cash equivalents | -77.65%776K | -82.99%751K | -51.33%1.82M | -41.63%3.13M | -41.63%3.13M | -10.24%3.47M | 12.29%4.41M | -33.59%3.75M | -28.54%5.36M | -28.54%5.36M |
| Receivables | -23.14%704K | -79.15%547K | -60.00%734K | -61.53%759K | -61.53%759K | -57.06%916K | 138.89%2.62M | -20.22%1.84M | 18.29%1.97M | 18.29%1.97M |
| -Accounts receivable | -23.14%704K | -79.15%547K | -60.00%734K | -61.53%759K | -61.53%759K | -57.06%916K | 138.89%2.62M | -20.22%1.84M | 18.29%1.97M | 18.29%1.97M |
| Inventory | -86.46%473K | -80.87%700K | -82.54%663K | -16.29%2.88M | -16.29%2.88M | -14.13%3.49M | -3.71%3.66M | 0.32%3.8M | 6.74%3.44M | 6.74%3.44M |
| Prepaid assets | -19.54%210K | -50.00%161K | -28.39%275K | -23.44%307K | -23.44%307K | -40.00%261K | -32.64%322K | -26.72%384K | -38.21%401K | -38.21%401K |
| Other current assets | 61.11%116K | -52.28%94K | -27.27%96K | -49.06%81K | -49.06%81K | -33.94%72K | 30.46%197K | -42.11%132K | 23.26%159K | 23.26%159K |
| Total current assets | -72.25%2.28M | -79.91%2.25M | -63.71%3.59M | -36.87%7.15M | -36.87%7.15M | -22.60%8.21M | 18.57%11.22M | -20.71%9.89M | -13.96%11.33M | -13.96%11.33M |
| Non current assets | ||||||||||
| Net PPE | -32.04%1.1M | -31.42%1.2M | -30.81%1.29M | -29.08%1.38M | -29.08%1.38M | -24.65%1.62M | -26.81%1.74M | -26.01%1.86M | 222.85%1.95M | 222.85%1.95M |
| -Gross PPE | -21.85%1.79M | -20.90%1.89M | -20.98%1.97M | -20.06%2.06M | -20.06%2.06M | -20.78%2.28M | -22.41%2.39M | -21.67%2.5M | 106.59%2.57M | 106.59%2.57M |
| -Accumulated depreciation | -3.18%-682K | -7.41%-696K | -7.87%-685K | -8.20%-673K | -8.20%-673K | 9.33%-661K | 7.43%-648K | 5.37%-635K | 2.96%-622K | 2.96%-622K |
| Goodwill and other intangible assets | ---- | ---- | ---- | --0 | --0 | -73.41%2.51M | -73.27%2.55M | -73.12%2.59M | -72.99%2.63M | -72.99%2.63M |
| -Goodwill | ---- | ---- | ---- | --0 | --0 | -92.31%348K | -92.31%348K | -92.31%348K | -92.31%348K | -92.31%348K |
| -Other intangible assets | ---- | ---- | ---- | ---- | ---- | -56.05%2.17M | -56.08%2.2M | -56.12%2.24M | -56.15%2.28M | -56.15%2.28M |
| Other non current assets | -1.20%495K | -4.03%476K | -0.21%477K | 1.64%497K | 1.64%497K | 227.45%501K | 217.95%496K | 196.89%478K | 2.73%489K | 2.73%489K |
| Total non current assets | -65.55%1.6M | -65.11%1.67M | -64.19%1.77M | -62.90%1.88M | -62.90%1.88M | -60.57%4.64M | -60.35%4.79M | -59.96%4.93M | -53.12%5.07M | -53.12%5.07M |
| Total assets | -69.83%3.88M | -75.48%3.93M | -63.87%5.36M | -44.91%9.03M | -44.91%9.03M | -42.56%12.85M | -25.70%16.01M | -40.21%14.83M | -31.61%16.4M | -31.61%16.4M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -58.18%396K | -16.61%1.24M | -2.70%1.12M | 4.63%1.13M | 4.63%1.13M | -13.67%947K | 59.25%1.48M | -26.22%1.15M | 3.35%1.08M | 3.35%1.08M |
| -accounts payable | -58.18%396K | -16.61%1.24M | -2.70%1.12M | 4.63%1.13M | 4.63%1.13M | -13.67%947K | 59.25%1.48M | -26.22%1.15M | 3.35%1.08M | 3.35%1.08M |
| Current accrued expenses | -52.12%396K | -44.14%524K | -44.87%521K | -37.84%570K | -37.84%570K | 77.85%827K | 18.58%938K | 11.31%945K | 14.20%917K | 14.20%917K |
| Current debt and capital lease obligation | -74.87%441K | -35.10%1.08M | 196.57%1.38M | 260.26%1.63M | 260.26%1.63M | 294.38%1.76M | 253.40%1.66M | 0.22%466K | 48.52%453K | 48.52%453K |
| -Current debt | -95.98%51K | -41.27%696K | --1.01M | --1.14M | --1.14M | --1.27M | --1.19M | ---- | ---- | ---- |
| -Current capital lease obligation | -19.59%390K | -19.75%382K | -19.53%375K | 9.27%495K | 9.27%495K | 8.99%485K | 1.28%476K | 0.22%466K | 126.50%453K | 126.50%453K |
| Current deferred liabilities | -27.93%751K | -57.46%773K | -60.03%745K | -47.65%946K | -47.65%946K | -38.81%1.04M | 23.94%1.82M | -2.61%1.86M | 40.19%1.81M | 40.19%1.81M |
| Other current liabilities | ---- | ---- | --159K | ---- | ---- | ---- | --169K | ---- | ---- | ---- |
| Current liabilities | -56.60%1.98M | -40.49%3.61M | -11.28%3.92M | 0.49%4.28M | 0.49%4.28M | 23.21%4.57M | 65.87%6.07M | -7.55%4.42M | 23.68%4.26M | 23.68%4.26M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -34.00%821K | -32.41%932K | -31.15%1.04M | -30.23%1.11M | -30.23%1.11M | -27.38%1.24M | -23.39%1.38M | -21.33%1.51M | 545.53%1.59M | 545.53%1.59M |
| -Long term capital lease obligation | -34.00%821K | -32.41%932K | -31.15%1.04M | -30.23%1.11M | -30.23%1.11M | -27.38%1.24M | -23.39%1.38M | -21.33%1.51M | 545.53%1.59M | 545.53%1.59M |
| Derivative product liabilities | ---- | --0 | --232K | --334K | --334K | ---- | ---- | ---- | --0 | --0 |
| Total non current liabilities | -34.00%821K | -32.41%932K | -15.81%1.27M | -9.19%1.44M | -9.19%1.44M | -74.52%1.24M | -35.62%1.38M | -33.22%1.51M | -84.68%1.59M | -84.68%1.59M |
| Total liabilities | -51.76%2.81M | -38.99%4.54M | -12.43%5.2M | -2.14%5.72M | -2.14%5.72M | -32.32%5.82M | 28.38%7.45M | -15.79%5.94M | -57.67%5.85M | -57.67%5.85M |
| Shareholders'equity | ||||||||||
| Share capital | -97.31%55K | -99.32%19K | -50.21%1.81M | -31.11%2.06M | -31.11%2.06M | 67.38%2.04M | 153.12%2.8M | 222.80%3.63M | 158.46%2.99M | 158.46%2.99M |
| -common stock | -24.62%49K | -98.07%13K | -50.92%320K | 460.00%112K | 460.00%112K | -90.00%65K | 25.79%673K | 26.85%652K | -95.82%20K | -95.82%20K |
| -Preferred stock | -99.70%6K | -99.72%6K | -50.05%1.49M | -34.41%1.95M | -34.41%1.95M | 246.84%1.98M | 272.63%2.12M | 388.18%2.97M | 337.21%2.97M | 337.21%2.97M |
| Retained earnings | -10.00%-182.25M | -9.82%-180.03M | -11.60%-178.44M | -10.56%-174.85M | -10.56%-174.85M | -10.49%-165.68M | -13.71%-163.92M | -12.60%-159.89M | -11.46%-158.15M | -11.46%-158.15M |
| Paid-in capital | 7.37%183.26M | 5.72%179.39M | 7.05%176.8M | 6.27%176.1M | 6.27%176.1M | 5.02%170.68M | 6.86%169.69M | 4.12%165.16M | 9.82%165.71M | 9.82%165.71M |
| Total stockholders'equity | -84.77%1.07M | -107.21%-617K | -98.20%160K | -68.60%3.31M | -68.60%3.31M | -48.95%7.04M | -45.61%8.56M | -49.90%8.89M | 3.77%10.55M | 3.77%10.55M |
| Total equity | -84.77%1.07M | -107.21%-617K | -98.20%160K | -68.60%3.31M | -68.60%3.31M | -48.95%7.04M | -45.61%8.56M | -49.90%8.89M | 3.77%10.55M | 3.77%10.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data